SMAD3 (SMAD family member 3)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
4088 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
SMAD family member 3 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
SMAD3 |
SynonymsGene synonyms aliases
|
HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 |
ChromosomeChromosome number
|
15 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
15q22.33 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene `mothers against decapentaplegic` (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. It also functions as a tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, Nov 2019] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs139616052 |
G>A |
Likely-benign, conflicting-interpretations-of-pathogenicity, uncertain-significance |
Coding sequence variant, synonymous variant |
rs201263330 |
G>C,T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs201912204 |
G>A |
Likely-benign, conflicting-interpretations-of-pathogenicity, uncertain-significance, benign |
Upstream transcript variant, intron variant, genic upstream transcript variant |
rs202094530 |
G>A |
Likely-benign, conflicting-interpretations-of-pathogenicity, uncertain-significance |
Coding sequence variant, missense variant |
rs387906850 |
C>T |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs387906851 |
C>T |
Pathogenic |
Coding sequence variant, missense variant |
rs387906852 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs387906853 |
G>A,T |
Risk-factor, likely-pathogenic, uncertain-significance |
Coding sequence variant, missense variant, stop gained |
rs387906854 |
C>T |
Uncertain-significance, pathogenic |
Coding sequence variant, upstream transcript variant, genic upstream transcript variant, missense variant |
rs387906855 |
C>G,T |
Likely-pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs387906856 |
G>A,C,T |
Uncertain-significance, pathogenic |
Coding sequence variant, missense variant, stop gained |
rs587776880 |
AT>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs587776881 |
A>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs587776882 |
G>- |
Pathogenic, not-provided |
Frameshift variant, coding sequence variant, upstream transcript variant, genic upstream transcript variant, 5 prime UTR variant |
rs587782977 |
G>A |
Uncertain-significance, likely-pathogenic |
Genic upstream transcript variant, coding sequence variant, missense variant, upstream transcript variant |
rs730880214 |
G>A |
Pathogenic, uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs730880215 |
G>A,T |
Pathogenic, likely-pathogenic |
Stop gained, coding sequence variant, missense variant |
rs745672741 |
G>A,C |
Pathogenic |
Genic upstream transcript variant, intron variant, upstream transcript variant |
rs753486471 |
C>A,T |
Pathogenic |
Stop gained, coding sequence variant, missense variant |
rs753875974 |
C>T |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Coding sequence variant, synonymous variant |
rs757106110 |
C>A,T |
Pathogenic, likely-benign |
Stop gained, synonymous variant, coding sequence variant |
rs768713596 |
C>T |
Pathogenic, likely-pathogenic |
5 prime UTR variant, upstream transcript variant, stop gained, genic upstream transcript variant, coding sequence variant |
rs770098673 |
G>C,T |
Likely-pathogenic |
Splice donor variant, genic upstream transcript variant |
rs776577220 |
G>A |
Conflicting-interpretations-of-pathogenicity |
Intron variant |
rs794727798 |
C>T |
Pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs863223737 |
G>A,C |
Uncertain-significance, likely-pathogenic, conflicting-interpretations-of-pathogenicity |
Coding sequence variant, missense variant |
rs863223738 |
G>C |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs863223740 |
G>A |
Uncertain-significance, pathogenic-likely-pathogenic |
Coding sequence variant, missense variant |
rs863223741 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs863223750 |
G>T |
Pathogenic |
Coding sequence variant, genic upstream transcript variant, stop gained |
rs863223754 |
->C |
Pathogenic |
Frameshift variant, coding sequence variant |
rs863223757 |
AG>- |
Likely-pathogenic |
Frameshift variant, upstream transcript variant, genic upstream transcript variant, coding sequence variant |
rs863223759 |
C>- |
Pathogenic |
Intron variant, upstream transcript variant, coding sequence variant, frameshift variant, genic upstream transcript variant |
rs863223761 |
T>C |
Likely-pathogenic |
Splice donor variant |
rs863223762 |
G>T |
Pathogenic |
Coding sequence variant, genic upstream transcript variant, stop gained |
rs863223768 |
T>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant |
rs863223770 |
->A |
Pathogenic |
Upstream transcript variant, coding sequence variant, genic upstream transcript variant, 5 prime UTR variant, stop gained |
rs863223771 |
C>- |
Pathogenic |
Intron variant, upstream transcript variant, coding sequence variant, frameshift variant, genic upstream transcript variant |
rs886038770 |
G>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs886038836 |
A>G |
Pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs886039177 |
A>G |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant |
rs958007552 |
C>A |
Conflicting-interpretations-of-pathogenicity |
Genic upstream transcript variant, intron variant, 5 prime UTR variant |
rs1057518977 |
G>T |
Likely-pathogenic |
Genic upstream transcript variant, 5 prime UTR variant, missense variant, upstream transcript variant, coding sequence variant |
rs1060500770 |
G>-,GGG |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1060500771 |
G>T |
Likely-pathogenic |
Splice donor variant |
rs1060500773 |
CACAC>- |
Pathogenic |
Intron variant, frameshift variant, genic upstream transcript variant, upstream transcript variant, coding sequence variant |
rs1064794789 |
G>- |
Likely-pathogenic |
Genic upstream transcript variant, stop gained, coding sequence variant |
rs1320208623 |
G>A,T |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1555405108 |
G>- |
Pathogenic |
Frameshift variant, coding sequence variant, genic upstream transcript variant |
rs1555412069 |
->G |
Pathogenic |
Upstream transcript variant, coding sequence variant, frameshift variant, 5 prime UTR variant, genic upstream transcript variant |
rs1555412070 |
->GC |
Pathogenic |
Upstream transcript variant, coding sequence variant, frameshift variant, 5 prime UTR variant, genic upstream transcript variant |
rs1555412294 |
C>- |
Pathogenic |
5 prime UTR variant, coding sequence variant, frameshift variant |
rs1555412629 |
T>- |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1555413562 |
G>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555414236 |
->TGTCTACCAGTTG |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1555414495 |
TCCTCACCCAGATGGG>- |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1555414503 |
G>A |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1566991387 |
G>A |
Likely-pathogenic |
5 prime UTR variant, genic upstream transcript variant, missense variant, coding sequence variant, upstream transcript variant |
rs1566999423 |
->GACA |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1566999458 |
C>T |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1566999601 |
T>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1566999610 |
A>G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1566999621 |
AGCTGACACGGAGA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1567002059 |
TAACCAGCGCTAT>GACACC |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1567002115 |
G>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1595941653 |
->GCC |
Pathogenic |
5 prime UTR variant, genic upstream transcript variant, coding sequence variant, inframe insertion, upstream transcript variant |
rs1595941823 |
GC>CT |
Likely-pathogenic |
Coding sequence variant, upstream transcript variant, missense variant, genic upstream transcript variant |
rs1595941909 |
C>- |
Likely-pathogenic |
Coding sequence variant, upstream transcript variant, frameshift variant, genic upstream transcript variant |
rs1595942351 |
C>- |
Pathogenic |
Genic upstream transcript variant, intron variant, coding sequence variant, frameshift variant, upstream transcript variant |
rs1595956416 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1595956538 |
G>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1595956573 |
->CAGTCATGGATGGCTGCGAGGCGTGGAATGTCTCCCCGACGCGCAGCCATCCA |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1595956832 |
G>A |
Pathogenic |
Splice donor variant |
rs1595960347 |
A>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1595960447 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1595962708 |
A>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1595965925 |
TG>- |
Pathogenic |
Coding sequence variant, frameshift variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT007291 |
hsa-miR-200a-3p |
Luciferase reporter assay |
22020340 |
MIRT007323 |
hsa-miR-18a-5p |
Western blot |
23249750 |
MIRT018567 |
hsa-miR-335-5p |
Microarray |
18185580 |
MIRT020918 |
hsa-miR-155-5p |
Western blot |
21036908 |
MIRT041360 |
hsa-miR-193b-3p |
CLASH |
23622248 |
MIRT041360 |
hsa-miR-193b-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
24496888 |
MIRT050933 |
hsa-miR-17-5p |
CLASH |
23622248 |
MIRT053644 |
hsa-miR-143-3p |
Microarray |
22942087 |
MIRT053650 |
hsa-miR-145-5p |
Microarray |
22942087 |
MIRT053650 |
hsa-miR-145-5p |
Luciferase reporter assay, Western blot, qRT-PCR, ELISA, Immunofluorescence |
24873879 |
MIRT053650 |
hsa-miR-145-5p |
Luciferase reporter assay |
23632450 |
MIRT072699 |
hsa-miR-3529-3p |
PAR-CLIP |
20371350 |
MIRT140820 |
hsa-miR-15a-5p |
HITS-CLIP |
22473208 |
MIRT140821 |
hsa-miR-16-5p |
HITS-CLIP |
22473208 |
MIRT140825 |
hsa-miR-15b-5p |
HITS-CLIP |
22473208 |
MIRT140827 |
hsa-miR-195-5p |
HITS-CLIP |
22473208 |
MIRT140830 |
hsa-miR-497-5p |
qRT-PCR |
27063509 |
MIRT193928 |
hsa-miR-142-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
27683030 |
MIRT193928 |
hsa-miR-142-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
26572508 |
MIRT438275 |
hsa-miR-491-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
25196641 |
MIRT438641 |
hsa-miR-92b-3p |
Immunohistochemistry, In situ hybridization, Luciferase reporter assay, qRT-PCR, Western blot |
23892108 |
MIRT497691 |
hsa-miR-4290 |
PAR-CLIP |
22291592 |
MIRT497692 |
hsa-miR-18a-3p |
PAR-CLIP |
22291592 |
MIRT731257 |
hsa-miR-323a-3p |
Immunoprecipitaion, Luciferase reporter assay, Western blot |
26908446 |
MIRT731257 |
hsa-miR-323a-3p |
qRT-PCR |
27059796 |
MIRT731442 |
hsa-miR-708-5p |
Luciferase reporter assay |
26932538 |
MIRT731517 |
hsa-miR-199a-5p |
Luciferase reporter assay |
27038547 |
MIRT732404 |
hsa-miR-145-3p |
ELISA, Luciferase reporter assay, qRT-PCR |
25704091 |
MIRT732665 |
hsa-miR-590-5p |
Luciferase reporter assay |
27054113 |
MIRT732727 |
hsa-miR-23a-3p |
Immunofluorescence, Luciferase reporter assay, qRT-PCR, Western blot |
27318087 |
MIRT732727 |
hsa-miR-23a-3p |
Luciferase reporter assay, Western blot |
27601936 |
MIRT733227 |
hsa-miR-23b-5p |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
26153982 |
MIRT733535 |
hsa-miR-424-5p |
Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
27655675 |
MIRT733893 |
hsa-miR-29b-1-5p |
qRT-PCR, Western blot |
27273381 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IDA |
8774881 |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IMP |
14555988 |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
TAS |
|
GO:0000785 |
Component |
Chromatin |
IDA |
21828274 |
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000976 |
Function |
Transcription regulatory region sequence-specific DNA binding |
IDA |
9732876 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA |
18832382, 21947082, 31582430 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IDA |
21947082 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0000987 |
Function |
Cis-regulatory region sequence-specific DNA binding |
IC |
21828274 |
GO:0000987 |
Function |
Cis-regulatory region sequence-specific DNA binding |
IDA |
21947082 |
GO:0001102 |
Function |
RNA polymerase II activating transcription factor binding |
IPI |
17251190 |
GO:0001223 |
Function |
Transcription coactivator binding |
IPI |
16777850 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IMP |
26311719 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
ISS |
24964035 |
GO:0001657 |
Process |
Ureteric bud development |
IEA |
|
GO:0001666 |
Process |
Response to hypoxia |
IMP |
12411310 |
GO:0001701 |
Process |
In utero embryonic development |
IEA |
|
GO:0001707 |
Process |
Mesoderm formation |
IEA |
|
GO:0001756 |
Process |
Somitogenesis |
IEA |
|
GO:0001889 |
Process |
Liver development |
IEA |
|
GO:0001947 |
Process |
Heart looping |
IEA |
|
GO:0002076 |
Process |
Osteoblast development |
IEA |
|
GO:0002520 |
Process |
Immune system development |
IEA |
|
GO:0003700 |
Function |
DNA-binding transcription factor activity |
IDA |
9732876, 10823886, 21947082 |
GO:0003700 |
Function |
DNA-binding transcription factor activity |
IDA |
9111321 |
GO:0005160 |
Function |
Transforming growth factor beta receptor binding |
IPI |
9311995 |
GO:0005515 |
Function |
Protein binding |
IPI |
9865696, 9892009, 10681527, 11274402, 11278756, 11387212, 12154125, 14525983, 14612439, 15084259, 15231748, 15350224, 15588252, 15647271, 15897867, 16007207, 16200078, 17099224, 17292623, 17469184, 17785517, 18548003, 18568018, 18729074, 18832382, 19032343, 19049980, 19122240, 19135 |
GO:0005518 |
Function |
Collagen binding |
IEA |
|
GO:0005634 |
Component |
Nucleus |
IDA |
9311995, 12446380, 16007207, 21145499, 21947082, 25893292 |
GO:0005634 |
Component |
Nucleus |
IGI |
23723426 |
GO:0005637 |
Component |
Nuclear inner membrane |
IDA |
15647271 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005667 |
Component |
Transcription regulator complex |
IDA |
21947082 |
GO:0005737 |
Component |
Cytoplasm |
IDA |
9311995, 12446380, 21145499, 21947082 |
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005829 |
Component |
Cytosol |
IGI |
23723426 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005886 |
Component |
Plasma membrane |
IEA |
|
GO:0006357 |
Process |
Regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0006357 |
Process |
Regulation of transcription by RNA polymerase II |
IDA |
21947082 |
GO:0006919 |
Process |
Activation of cysteine-type endopeptidase activity involved in apoptotic process |
IMP |
15107418 |
GO:0006955 |
Process |
Immune response |
IMP |
16886151 |
GO:0007050 |
Process |
Cell cycle arrest |
IMP |
14555988 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IBA |
21873635 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IDA |
9732876, 18548003, 21947082 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
TAS |
|
GO:0007183 |
Process |
SMAD protein complex assembly |
IDA |
9111321, 10823886 |
GO:0007492 |
Process |
Endoderm development |
IEA |
|
GO:0008013 |
Function |
Beta-catenin binding |
IEA |
|
GO:0008134 |
Function |
Transcription factor binding |
IPI |
9732876, 21828274 |
GO:0008270 |
Function |
Zinc ion binding |
IDA |
12686552 |
GO:0009653 |
Process |
Anatomical structure morphogenesis |
IBA |
21873635 |
GO:0009880 |
Process |
Embryonic pattern specification |
IEA |
|
GO:0010628 |
Process |
Positive regulation of gene expression |
IDA |
21307346 |
GO:0010694 |
Process |
Positive regulation of alkaline phosphatase activity |
IEA |
|
GO:0010718 |
Process |
Positive regulation of epithelial to mesenchymal transition |
IDA |
21307346 |
GO:0010718 |
Process |
Positive regulation of epithelial to mesenchymal transition |
IMP |
18505915 |
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0016202 |
Process |
Regulation of striated muscle tissue development |
IEA |
|
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0017015 |
Process |
Regulation of transforming growth factor beta receptor signaling pathway |
IMP |
8774881 |
GO:0017151 |
Function |
DEAD/H-box RNA helicase binding |
IPI |
18548003 |
GO:0019901 |
Function |
Protein kinase binding |
IPI |
12874272 |
GO:0019902 |
Function |
Phosphatase binding |
IPI |
16751101 |
GO:0023019 |
Process |
Signal transduction involved in regulation of gene expression |
IEA |
|
GO:0030154 |
Process |
Cell differentiation |
IBA |
21873635 |
GO:0030308 |
Process |
Negative regulation of cell growth |
IDA |
8774881 |
GO:0030325 |
Process |
Adrenal gland development |
IEA |
|
GO:0030335 |
Process |
Positive regulation of cell migration |
IEA |
|
GO:0030501 |
Process |
Positive regulation of bone mineralization |
IEA |
|
GO:0030509 |
Process |
BMP signaling pathway |
IBA |
21873635 |
GO:0030512 |
Process |
Negative regulation of transforming growth factor beta receptor signaling pathway |
TAS |
|
GO:0030878 |
Process |
Thyroid gland development |
IEA |
|
GO:0031053 |
Process |
Primary miRNA processing |
TAS |
19018011 |
GO:0031490 |
Function |
Chromatin DNA binding |
IEA |
|
GO:0031625 |
Function |
Ubiquitin protein ligase binding |
IPI |
11278251, 19122240 |
GO:0031962 |
Function |
Mineralocorticoid receptor binding |
IPI |
12902338 |
GO:0032332 |
Process |
Positive regulation of chondrocyte differentiation |
IEA |
|
GO:0032731 |
Process |
Positive regulation of interleukin-1 beta production |
IEA |
|
GO:0032909 |
Process |
Regulation of transforming growth factor beta2 production |
IMP |
12411310 |
GO:0032916 |
Process |
Positive regulation of transforming growth factor beta3 production |
IEA |
|
GO:0032924 |
Process |
Activin receptor signaling pathway |
IMP |
15150278 |
GO:0033689 |
Process |
Negative regulation of osteoblast proliferation |
IEA |
|
GO:0035259 |
Function |
Glucocorticoid receptor binding |
IPI |
12902338 |
GO:0038092 |
Process |
Nodal signaling pathway |
IMP |
15150278 |
GO:0042060 |
Process |
Wound healing |
TAS |
19018011 |
GO:0042110 |
Process |
T cell activation |
IEA |
|
GO:0042177 |
Process |
Negative regulation of protein catabolic process |
IEA |
|
GO:0042307 |
Process |
Positive regulation of protein import into nucleus |
NAS |
15799969 |
GO:0042802 |
Function |
Identical protein binding |
IPI |
18729074, 22045334 |
GO:0042803 |
Function |
Protein homodimerization activity |
IPI |
8774881 |
GO:0043066 |
Process |
Negative regulation of apoptotic process |
IEA |
|
GO:0043130 |
Function |
Ubiquitin binding |
IDA |
18794808 |
GO:0043235 |
Component |
Receptor complex |
IMP |
8774881 |
GO:0043425 |
Function |
BHLH transcription factor binding |
IPI |
21828274 |
GO:0043565 |
Function |
Sequence-specific DNA binding |
IDA |
10823886 |
GO:0045216 |
Process |
Cell-cell junction organization |
IMP |
18505915 |
GO:0045429 |
Process |
Positive regulation of nitric oxide biosynthetic process |
IDA |
27038547 |
GO:0045599 |
Process |
Negative regulation of fat cell differentiation |
IDA |
19816956 |
GO:0045668 |
Process |
Negative regulation of osteoblast differentiation |
IEA |
|
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
9111321, 9311995, 9732876 |
GO:0045930 |
Process |
Negative regulation of mitotic cell cycle |
IMP |
14555988 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
8774881, 18832382 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
14555988 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
TAS |
|
GO:0048340 |
Process |
Paraxial mesoderm morphogenesis |
IEA |
|
GO:0048589 |
Process |
Developmental growth |
IEA |
|
GO:0048617 |
Process |
Embryonic foregut morphogenesis |
IEA |
|
GO:0048701 |
Process |
Embryonic cranial skeleton morphogenesis |
IEA |
|
GO:0050678 |
Process |
Regulation of epithelial cell proliferation |
IEA |
|
GO:0050728 |
Process |
Negative regulation of inflammatory response |
IEA |
|
GO:0050776 |
Process |
Regulation of immune response |
IEA |
|
GO:0050821 |
Process |
Protein stabilization |
IEA |
|
GO:0050927 |
Process |
Positive regulation of positive chemotaxis |
IEA |
|
GO:0051091 |
Process |
Positive regulation of DNA-binding transcription factor activity |
NAS |
15799969 |
GO:0051098 |
Process |
Regulation of binding |
IEA |
|
GO:0051481 |
Process |
Negative regulation of cytosolic calcium ion concentration |
IDA |
27038547 |
GO:0051496 |
Process |
Positive regulation of stress fiber assembly |
IEA |
|
GO:0051894 |
Process |
Positive regulation of focal adhesion assembly |
IEA |
|
GO:0060039 |
Process |
Pericardium development |
IEA |
|
GO:0060290 |
Process |
Transdifferentiation |
IEA |
|
GO:0060395 |
Process |
SMAD protein signal transduction |
IBA |
21873635 |
GO:0060395 |
Process |
SMAD protein signal transduction |
NAS |
15799969 |
GO:0061045 |
Process |
Negative regulation of wound healing |
IEA |
|
GO:0061767 |
Process |
Negative regulation of lung blood pressure |
IEA |
|
GO:0070306 |
Process |
Lens fiber cell differentiation |
IEA |
|
GO:0070410 |
Function |
Co-SMAD binding |
IPI |
8774881, 9111321, 9311995, 9732876 |
GO:0070411 |
Function |
I-SMAD binding |
IBA |
21873635 |
GO:0070412 |
Function |
R-SMAD binding |
IPI |
9311995, 20129061 |
GO:0071141 |
Component |
SMAD protein complex |
IDA |
18832382, 21947082 |
GO:0071144 |
Component |
Heteromeric SMAD protein complex |
IBA |
21873635 |
GO:0071144 |
Component |
Heteromeric SMAD protein complex |
IDA |
21828274 |
GO:0071345 |
Process |
Cellular response to cytokine stimulus |
TAS |
|
GO:0071560 |
Process |
Cellular response to transforming growth factor beta stimulus |
IDA |
12902338 |
GO:0090263 |
Process |
Positive regulation of canonical Wnt signaling pathway |
IEA |
|
GO:0097191 |
Process |
Extrinsic apoptotic signaling pathway |
IMP |
15334054 |
GO:0097296 |
Process |
Activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
IEA |
|
GO:1901203 |
Process |
Positive regulation of extracellular matrix assembly |
IDA |
21307346 |
GO:1902895 |
Process |
Positive regulation of pri-miRNA transcription by RNA polymerase II |
IMP |
26311719 |
GO:1903243 |
Process |
Negative regulation of cardiac muscle hypertrophy in response to stress |
IEA |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P84022 |
Protein name |
Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) |
Protein function |
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. |
PDB |
1MHD
,
1MJS
,
1MK2
,
1OZJ
,
1U7F
,
2LAJ
,
2LB2
,
5OD6
,
5ODG
,
5XOC
,
6ZMN
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF03165 |
MH1 |
31 → 131 |
MH1 domain |
Domain |
PF03166 |
MH2 |
230 → 401 |
MH2 domain |
Family |
|
Sequence |
|
Sequence length |
425 |
Interactions |
View interactions |
|
|